Rovertis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-05-2024
- Paid Up Capital ₹ 0.96 M
as on 24-05-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -5.75%
(FY 2016)
- Ebitda 224.77%
(FY 2016)
- Net Worth 7.78%
(FY 2016)
- Total Assets 1.15%
(FY 2016)
About Rovertis Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.96 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnam Vegesna, Rajitha Rajaboina, Sreenivasa Devarakonda, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC044325
- Company No.
044325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rovertis Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnam Vegesna  | Director | 04-Oct-2004 | Current |
| Rajitha Rajaboina | Director | 20-Dec-2010 | Current |
| Sreenivasa Devarakonda | Director | 20-Dec-2010 | Current |
| Swarupa Chintala | Director | 04-Oct-2004 | Current |
| Swarna Pagadala | Director | 04-Oct-2004 | Current |
| Padma Rajaboina | Director | 04-Oct-2004 | Current |
Financial Performance of Rovertis Pharmaceuticals.
Rovertis Pharmaceuticals Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 5.75% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 7.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rovertis Pharmaceuticals?
In 2016, Rovertis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rovertis Pharmaceuticals?
Unlock and access historical data on people associated with Rovertis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rovertis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rovertis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
